{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:11:18Z","timestamp":1790244678615,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1007\/bf02982044","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T08:14:37Z","timestamp":1226304877000},"page":"289-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Biological Significance of Proliferation, Apoptosis, Cytokines, and Monocyte\/Macrophage Cells in Bone Marrow Biopsies of 145 Patients With Myelodysplastic Syndrome"],"prefix":"10.1007","volume":"75","author":[{"given":"Krishnan","family":"Allampallam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilasini","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneel","family":"Mundle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diya","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Kravitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poluru L.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairah","family":"Alvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Galili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurveen S.","family":"Saberwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Anthwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliha W.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azra","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,4,1]]},"reference":[{"key":"BF02982044_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1046\/j.1365-201X.1997.00107.x","volume":"159","author":"PO Iverson","year":"1997","unstructured":"Iverson PO. Blood flow to the hematopoietic bone marrow.Acta Physiol Scand. 1997;159:269\u2013276.","journal-title":"Acta Physiol Scand"},{"key":"BF02982044_CR2","volume-title":"Blood and Bone Marrow","author":"SN Wickramasinghe","year":"1986","unstructured":"Wickramasinghe SN.Blood and Bone Marrow. 3rd ed. London, England: Churchill Livingstone; 1986.","edition":"3rd ed."},{"key":"BF02982044_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/1040-8428(96)00197-7","volume":"23","author":"JF San Miguel","year":"1996","unstructured":"San Miguel JF, Sanz GF, Vellaspi T, Canizo MC, Sanz MA. Myelodysplastic syndromes.Crit Rev Oncol Hematol. 1996;23:57\u201393.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF02982044_CR4","first-page":"191","volume":"5","author":"L Resegotti","year":"1993","unstructured":"Resegotti L. The nature and natural history of myelodysplasia.Haematologica. 1993;5:191\u2013204.","journal-title":"Haematologica"},{"key":"BF02982044_CR5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V86.1.268.bloodjournal861268","volume":"86","author":"A Raza","year":"1995","unstructured":"Raza A, Gezer S, Mundle S, Gao XZ, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes.Blood. 1995;86:268\u2013276.","journal-title":"Blood"},{"key":"BF02982044_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0145-2126(96)00027-6","volume":"20","author":"A Raza","year":"1996","unstructured":"Raza A, Gregory SA, Preisler HD. The myelodysplastic syndromes in 1996: complex stem cell disorders confounded by dual actions of cytokines.Leuk Res. 1996;20:881\u2013890.","journal-title":"Leuk Res."},{"key":"BF02982044_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/BF03032653","volume":"6","author":"L Molnar","year":"2000","unstructured":"Molnar L, Berki T, Hussain A, et al. Detection of TNF alpha expression in the bone marrow and determination of TNF alpha production of peripheral blood mononuclear cells in myelodysplastic syndrome.Pathol Oncol Res. 2000;6:18\u201323.","journal-title":"Pathol Oncol Res."},{"key":"BF02982044_CR8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0145-2126(96)00008-2","volume":"20","author":"V Shetty","year":"1996","unstructured":"Shetty V, Mundle S, Alvi S, et al. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.Leuk Res. 1996;20:891\u2013900.","journal-title":"Leuk Res."},{"key":"BF02982044_CR9","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood.V88.7.2640.bloodjournal8872640","volume":"88","author":"SD Mundle","year":"1996","unstructured":"Mundle SD, Venugopal P, Pandav DV, et al. Indication of an involvement of interleukin-1\u03b2 converting enzyme (ICE)-like protease in intramedullary apoptotic cell death in the bone marrows of patients with myelodysplastic syndromes (MDS).Blood. 1996;88:2640\u20132647.","journal-title":"Blood"},{"key":"BF02982044_CR10","first-page":"5323","volume":"19","author":"K Allampallam","year":"1999","unstructured":"Allampallam K, Shetty V, Hussaini S, et al. Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes.Anticancer Res. 1999;19:5323\u20135328.","journal-title":"Anticancer Res."},{"key":"BF02982044_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1365-2141.1997.4373247.x","volume":"99","author":"CM Peddie","year":"1997","unstructured":"Peddie CM, Wolf CR, McLellan LI, Collins AR, Bowen DT. Oxidative DNA damage in CD34- myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-\u03b2 concentration.Br J Haematol. 1997;99:625\u2013631.","journal-title":"Br J Haematol"},{"key":"BF02982044_CR12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood.V77.2.413.413","volume":"77","author":"N Zoumbos","year":"1991","unstructured":"Zoumbos N, Symeonidis A, Kourakli A, et al. Increased levels of soluble interleukin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes.Blood. 1991;77:413\u2013414.","journal-title":"Blood"},{"key":"BF02982044_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0145-2126(92)90006-S","volume":"16","author":"M Herold","year":"1992","unstructured":"Herold M, Schmalzl F, Zwierzina H. Increased serum interleukin 6 levels in patients with myelodysplastic syndromes.Leuk Res. 1992;16:585\u2013588.","journal-title":"Leuk Res."},{"key":"BF02982044_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/10428199409051688","volume":"15","author":"C Mareni","year":"1994","unstructured":"Mareni C, Sessarego M, Montera M, et al. Expression and genomic configuration of GM-CSF, IL-3 M-CSF receptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes.Leuk Lymphoma. 1994;15:135\u2013141.","journal-title":"Leuk Lymphoma"},{"key":"BF02982044_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1365-2141.1998.00933.x","volume":"103","author":"GM Gersuk","year":"1998","unstructured":"Gersuk GM, Beckham C, Loken MR, et al. A role for tumour necrosis factor-\u03b2, FAS and FAS-Ligand in marrow failure associated with myelodysplastic syndrome.Br J Haematol. 1998;103:176\u2013188.","journal-title":"Br J Haematol"},{"key":"BF02982044_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/sj.leu.2400980","volume":"12","author":"M Kitagawa","year":"1998","unstructured":"Kitagawa M, Yamaguchi S, Takahashi M, Tanizawa T, Hirokawa K, Kamiyama R. Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia.Leukemia. 1998;12:486\u2013492.","journal-title":"Leukemia"},{"key":"BF02982044_CR17","first-page":"83","volume":"70","author":"S Mundle","year":"1999","unstructured":"Mundle S, Mativi BY, Bagai K, et al. Spontaneous down-regulation of Fas-associated phosphatase-1 (Fap-1) may contribute to the excessive apoptosis in myelodysplastic marrows.Int J Hematol. 1999;70:83\u201390.","journal-title":"Int J Hematol"},{"key":"BF02982044_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/978-3-642-71960-8_5","volume-title":"Acute Leukemias VII: Experimental Approaches and Novel Therapies","author":"A Raza","year":"1998","unstructured":"Raza A, Venugopal P, Gezer S, et al. Pilot study of pentoxifylline and Ciprofloxacin with or without dexamethasone produces encouraging results in myelodysplastic syndromes. In: Hiddemann W, Buchner T, Wormann B, Ritter J, Creutzig U, Keating M, Plunkett W, eds.Acute Leukemias VII: Experimental Approaches and Novel Therapies. New York, NY: Springer-Verlag; 1998:42\u201351."},{"key":"BF02982044_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/10245332.2000.11746517","volume":"5","author":"A Raza","year":"2000","unstructured":"Raza A, Qawi H, Andric T, et al. Pentoxifylline, Ciprofloxacin and dexamethasone improve the ineffective hematopoiesis in myelodysplastic syndrome patients.Hematology. 2000;5:275\u2013284.","journal-title":"Hematology"},{"key":"BF02982044_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/1097-0029(20000801)50:3<229::AID-JEMT6>3.0.CO;2-H","volume":"50","author":"A Raza","year":"2000","unstructured":"Raza A. Anti-TNF therapies in rheumatoid arthritis, Crohn\u2019s disease, sepsis, and myelodysplastic syndromes.Microsc Res Tech. 2000;50:229\u2013235.","journal-title":"Microsc Res Tech."},{"key":"BF02982044_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Flandrin DMT, Galton DGAD, Gralnick HR, Sultan C. Proposal for the classification of myelodysplastic syndromes.Br J Haematol. 1982;51:189\u2013199.","journal-title":"Br J Haematol"},{"key":"BF02982044_CR22","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"PL Greenberg","year":"1997","unstructured":"Greenberg PL, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes.Blood. 1997;89:2079\u20132088.","journal-title":"Blood"},{"key":"BF02982044_CR23","first-page":"530","volume":"25","author":"A Raza","year":"1997","unstructured":"Raza A, Alvi S, Broady-Robinson L, et al. Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and\/or bromodeoxyuride.Exp Hematol. 1997;25:530\u2013535.","journal-title":"Exp Hematol"},{"key":"BF02982044_CR24","first-page":"301","volume":"2","author":"A Raza","year":"1993","unstructured":"Raza A, Yousuf N, Bokhari SAJ, et al. Cell cycle characteristics: alterable determinants of remission duration in a study of 179 standard risk newly diagnosed patients with acute myeloid leukemia.Int J Oncol. 1993;2:301\u2013307.","journal-title":"Int J Oncol"},{"key":"BF02982044_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ajh.2830480302","volume":"48","author":"A Raza","year":"1995","unstructured":"Raza A, Mundle S, Iftikhar A, et al. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis.Am J Hematol. 1995;48:143\u2013154.","journal-title":"Am J Hematol"},{"key":"BF02982044_CR26","first-page":"1648","volume":"10","author":"A Raza","year":"1996","unstructured":"Raza A, Mundle S, Shetty V, et al. A paradigm shift in myelodysplastic syndromes.Leukemia. 1996;10:1648\u20131652.","journal-title":"Leukemia"},{"key":"BF02982044_CR27","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1182\/blood.V88.11.4275.4275","volume":"88","author":"R Rajapaksa","year":"1996","unstructured":"Rajapaksa R, Ginzton N, Rott LS, Greenberg PL. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells.Blood. 1996;88:4275\u20134287.","journal-title":"Blood"},{"key":"BF02982044_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0609.1999.tb01109.x","volume":"62","author":"A Parcharidou","year":"1999","unstructured":"Parcharidou A, Raza A, Economopoulos T, et al. Extensive apoptosis of bone marrow cells as evaluated by the in-situ end labeling (ISEL) technique may be the basis for ineffective hematopoiesis in patients with myelodysplastic syndromes.Eur J Haematol. 1999;62:19\u201326.","journal-title":"Eur J Haematol"},{"key":"BF02982044_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1046\/j.1365-2141.2000.02228.x","volume":"110","author":"K Shimazaki","year":"2000","unstructured":"Shimazaki K, Ohshima K, Suzumiya J, Kawasaki C, Kijuchi M. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.Br J Hematol. 2000;110:584\u2013590.","journal-title":"Br J Hematol"},{"key":"BF02982044_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/BF02826211","volume":"17","author":"AA Van de Loosdrecht","year":"2000","unstructured":"Van de Loosdrecht AA, Vellenga E. Myelodysplasia and apoptosis: new insights into ineffective erythropoiesis.Med Oncol. 2000;17:16\u201321.","journal-title":"Med Oncol"},{"key":"BF02982044_CR31","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood.V96.12.3932","volume":"96","author":"JE Parker","year":"2000","unstructured":"Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.Blood. 2000;96:3932\u20133938.","journal-title":"Blood"},{"key":"BF02982044_CR32","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V96.4.1388","volume":"96","author":"V Shetty","year":"2000","unstructured":"Shetty V, Hussaini S, Broady-Robinson L, Allampallam K, et al. Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high density fraction of bone marrow aspirates.Blood. 2000;96:1388\u20131392.","journal-title":"Blood"},{"key":"BF02982044_CR33","first-page":"185","volume":"37","author":"S Alvi","year":"1996","unstructured":"Alvi S, Borok R, Showel M, et al. Formation of large molecular weight DNA fragments may be a committed step of apoptosis in myelodysplastic syndromes vs acute myeloid leukemia [abstract].Proc Am Assoc Cancer Res. 1996;37:Abstract 185.","journal-title":"Proc Am Assoc Cancer Res."},{"key":"BF02982044_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-0609.1999.tb01763.x","volume":"63","author":"HA Papadaki","year":"1999","unstructured":"Papadaki HA, Giouremou K, Eliopoulos GD. Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-\u03b2 by bone marrow stromal cells.Eur J Haematol. 1999;63:154\u2013162.","journal-title":"Eur J Haematol"},{"key":"BF02982044_CR35","doi-asserted-by":"publisher","first-page":"14769","DOI":"10.1073\/pnas.95.25.14769","volume":"95","author":"L Vindevoghel","year":"1998","unstructured":"Vindevoghel L, Lechleider RJ, Kon A, et al. SMADk3\/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor \u03b2.Proc Natl Acad Sci U S A. 1998;95:14769\u201314774.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"BF02982044_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1600-0609.1999.tb01727.x","volume":"62","author":"S Dar","year":"1999","unstructured":"Dar S, Mundle S, Andric T, et al. Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis.Eur J Haematol. 1999;62:90\u201394.","journal-title":"Eur J Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02982044\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02982044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T21:35:55Z","timestamp":1589060155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02982044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["BF02982044"],"URL":"https:\/\/doi.org\/10.1007\/bf02982044","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}